SCHEMBL23975259

SCHEMBL23975259

CC(C)(C)NCC(=O)NCCCCCCCCNC(=O)C(C)(C)C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
ALDH1A1 P00352 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
EPHX1 P07099 1/20 0.41
CASP2 P42575 1/20 0.39
KDM4E B2RXH2 2/20 0.38
MAPK1 P28482 1/20 0.38
HIF1A Q16665 1/20 0.38
DRD2 P14416 5/20 0.37
DRD4 P21917 5/20 0.37
NAAA Q02083 1/20 0.37
MAPT P10636 1/20 0.36
CA12 O43570 1/20 0.35
CA2 P00918 1/20 0.35
CA3 P07451 1/20 0.35
CA4 P22748 1/20 0.35
CA6 P23280 1/20 0.35
CA5A P35218 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23975102 0.85 MEN1 (0.48) POLBMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL21842268 0.84 MEN1 (0.44) POLBMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL23790074 0.84 KDM4E (0.59) MEN1KMT2AALDH1A1SMN1; SMN2EPHX1
SCHEMBL23594056 0.83 POLB (0.49) POLBMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL10633351 0.82 MEN1 (0.58) POLBMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL23975255 0.81 MEN1 (0.39) POLBMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL19767693 0.81 TP53BP1 (0.43) POLBMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL18622113 0.80 POLB (0.57) POLBMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL20805238 0.80 MEN1 (0.42) POLBMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL23975095 0.79 POLB (0.41) POLBMEN1KMT2AALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210338825-A1 DEGRADERS OF HEPATITIS C VIRUS NS3/4A PROTEIN DANA-FARBER CANCER INSTITUTE, INC. (US) 2021-11-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210338825-A1 DEGRADERS OF HEPATITIS C VIRUS NS3/4A PROTEIN HAVCR2, CUL4A, PSMC3 POLB 2662/4885MEN1 4716/4885KMT2A 1752/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.